OCT 14, 2016 11:14 AM PDT

T Cell Infusion Method Enhances Anti-Cancer Effect

WRITTEN BY: Kara Marker
Enhancing a cancer patient’s own T cells to reduce tumor growth is an up-and-coming cancer therapy that is being used to treat multiple types of tumor growth. A new study from the Medical University of South Carolina, in collaboration with Loyola University, offers a new way to insure that the enhanced T cells survived once they re-enter the body.
Credit: Medical University of South Carolina
Adoptive cell therapy (ACT) began as an immune-boosting cancer treatment as scientists began infusing autologous, melanoma-specific T cells obtained from the patient’s own supply of cells. After obtaining the cells, researchers genetically modify them with therapeutic receptors, activate them, and then stimulate them to proliferating before facilitating a therapeutic re-infusion back into the patient’s bloodstream. 

Unfortunately, rapid proliferation before reinfusion makes T cells increasingly prone to activation induced cell death (AICD), and the best results only occur when the transferred enhanced T cells survive. Fast-forward to this study and the authors’ current goals: how can they prevent AICD to enhance ACT’s effectiveness at targeting cancer, mainly melanoma? After extensive experimentation, they found that culturing the T cells in N-acetyl cysteine (NAC) before re-infusion protects them from AICD, making the immunotherapy increasingly effective and outcomes much more promising in a preclinical model of melanoma.

The collaborative effort led to the researchers seeing significant improvements in T cell persistence and overall outcomes when they added NAC to the in vitro T cell expansion culture. Apparently, NAC prevents increases in a DNA damage marker called yH2AX. Specifically, 40 percent of NAC-cultured T cells were detectable in tumors post-re-infusion as compared to only 1.2 percent of standard-culture T cells. 

"We were really surprised," said senior author of the recent Cancer Research study Christina Voelkel-Johnson, PhD, from the Medical University of South Carolina. "Given the harsh environment T cells encounter within tumors, we did not expect that the number of NAC-cultured T cells would be 33-fold higher than T cells not cultured in NAC." Plus, in mice models, they saw a significant delay of tumor growth in mice receiving T cell re-infusion after being cultured in NAC.

Their studies show that NAC culture reduces the level of reactive oxygen species (ROS), which reduces the amount of damage done to the DNA through an extensive molecular pathway of kinases, tumor proteins, and antibodies. When less DNA damage occurs in T cells, the body’s regulatory cells don’t have to make a choice between repair and cell death, reducing the overall rate of T cells destroyed because of DNA damage.

Next up: how does NAC culturing of T cells affect their phenotype? How does it work? In Voelkel-Johnson’s words: “There may be benefits to culturing T cells in NAC aside from generating AICD resistance that we haven't yet recognized."

More about melanoma:

Melanoma is a cancer that begins in the melanocytes. It’s less common than basal cell and squamous cell skin cancers, but it’s more dangerous because it is more likely to metastasize if not treated early. The American Cancer Society estimates that more than ten thousand people in the United States will die from melanoma in 2016.
 


Sources: Medical University of South Carolina, American Cancer Society
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 24, 2019
Immunology
SEP 24, 2019
Flu Shot Less Effective Due to Overuse of Antibioitics
New research out of the Stanford University School of Medicine shows that the consequence of overuse of antibiotics lowers the effectiveness of the seasona...
SEP 27, 2019
Immunology
SEP 27, 2019
Diseases We Share with Our Canine Companions: Autoimmune Encephalitis in Dogs
Like humans, dogs can develop autoimmune encephalitis, and it’s common - mostly affecting smaller breeds and young adult dogs. Now scientists underst...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Effective Vaccines for Lyme Disease?
Currently, there are no effective vaccines available for the presentation of Lyme disease. The only preventive efforts present includes “guiding&rdqu...
NOV 10, 2019
Drug Discovery & Development
NOV 10, 2019
Promising Results for New Vaccine Against Dengue Fever
Dengue fever is an illness transmitted by mosquito bites. Affecting around 390 million people per year, if left untreated, its mortality rate is 20%. Altho...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Antibiotic Usage May Cause Parkinson's, Study Finds
A study from Helsinki University Hospital, Finland suggests that excessive usage of certain antibiotics may increase one’s risk of developing Parkins...
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti...
Loading Comments...